来凯医药-B：拟配售1763.6万股 净筹约2.3亿港元

Group 1 - The company, Lai Kai Pharmaceutical-B, announced an agreement with a sole placement agent to issue 17.636 million shares at a price of HKD 13.36 per share, representing a discount of 15.01% compared to the previous trading day's closing price [1] - The expected net fundraising amount is approximately HKD 230 million, which will be used to accelerate the research and development of drug assets such as LAE102 [1]